March 18, 2019
Pascal Biosciences (TSXV:PAS) has announced it has entered into a partnership with Mitacs for a multi-year cancer research project at...
February 3, 2019
The multibillion-dollar immunotherapy market is expected to experience further growth on advancements in checkpoint inhibitor biotechnology.
December 3, 2018
What gene therapy companies should be on investors' radar? Here are four promising companies to consider looking at in 2018.
May 9, 2018
OncoMed Pharmaceuticals (NASDAQ:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, today announced first quarter 2018...
April 29, 2018
Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 18, 2018
With Q1 2018 behind us, here the Investing News Network looks back on some of the biggest trends of the...
April 17, 2018
CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced the presentation of...